Us Bancorp \De\ Biomea Fusion, Inc. Transaction History
Us Bancorp \De\
- $74.1 Billion
- Q1 2025
Shares
4 transactions
Others Institutions Holding BMEA
# of Institutions
109Shares Held
16.1MCall Options Held
229KPut Options Held
354K-
Cormorant Asset Management, LP Boston, MA3.57MShares$5.28 Million0.81% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$3.47 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.38MShares$2.04 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY799KShares$1.18 Million0.59% of portfolio
-
Geode Capital Management, LLC Boston, MA626KShares$926,4100.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $43.4M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...